Michelle Sands

Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design

Ping Wei, Marlena Walls, Ming Qiu et al. · Molecular Cancer Therapeutics · 2010 · 195 citations · Full text

Life Sciences, Oncology, Pharmacology +15

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans

Juraj Koška, Michelle Sands, Camelia Burciu et al. · Diabetes · 2015 · 166 citations · Full text

Medicine, Endocrinology, Pharmacology +17

A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease

Christine Costello, Brian McCullagh, Katherine B. Howell et al. · European Respiratory Journal · 2011 · 55 citations · Full text

Veterinary Medicine, Molecular Medicine, Pathobiology +15

The pathophysiological basis of chronic hypoxic pulmonary hypertension in the mouse: vasoconstrictor and structural mechanisms contribute equally

Edwina Cahill, Simon C. Rowan, Michelle Sands et al. · Experimental Physiology · 2012 · 48 citations · Full text

Life Sciences, Physiology, Animal Physiology +16

<scp>l</scp> -Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension

K. M. Howell, Christine Costello, Michelle Sands et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2009 · 44 citations

Medicine, Pharmacology, Hemodynamic Management +12